Unraveling the Detoxification Mechanism of 2,4-Dichlorophenol by Marine-Derived Mesophotic Symbiotic Fungi Isolated from Marine Invertebrates.


Journal

Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729

Informations de publication

Date de publication:
30 Sep 2019
Historique:
received: 31 08 2019
revised: 24 09 2019
accepted: 26 09 2019
entrez: 3 10 2019
pubmed: 3 10 2019
medline: 28 2 2020
Statut: epublish

Résumé

Chlorophenols (CPs) are environmental pollutants that are produced through various anthropogenic activities and introduced in the environment. Living organisms, including humans, are exposed to these toxic xenobiotics and suffer from adverse health effects. More specifically, 2,4-dichlorophenol (2,4-DCP) is released in high amounts in the environment and has been listed as a priority pollutant by the US Environmental Protection Agency. Bioremediation has been proposed as a sustainable alternative to conventional remediation methods for the detoxification of phenolic compounds. In this work, we studied the potential of fungal strains isolated as symbionts of marine invertebrates from the underexplored mesophotic coral ecosystems. Hence, the unspecific metabolic pathways of these fungal strains are being explored in the present study, using the powerful analytical capabilities of a UHPLC-HRMS/MS. The newly identified 2,4-DCP metabolites add significantly to the knowledge of the transformation of such pollutants by fungi, since such reports are scarce.

Identifiants

pubmed: 31575010
pii: md17100564
doi: 10.3390/md17100564
pmc: PMC6835501
pii:
doi:

Substances chimiques

Chlorophenols 0
Phenols 0
Water Pollutants, Chemical 0
Xenobiotics 0
2,4-dichlorophenol R669TG1950

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Horizon 2020
ID : 634674
Organisme : State Scholarships Foundation
ID : MIS-5000432

Références

Front Microbiol. 2017 Feb 20;8:265
pubmed: 28265269
Appl Microbiol Biotechnol. 2011 Aug;91(3):811-21
pubmed: 21556917
Appl Microbiol Biotechnol. 1998 Sep;50(3):379-83
pubmed: 9802224
FEMS Microbiol Lett. 1996 May 1;138(2-3):221-6
pubmed: 9026450
J Bacteriol. 1993 May;175(9):2640-4
pubmed: 8478329
Biotechnol Lett. 2013 Jul;35(7):1079-83
pubmed: 23515893
Environ Pollut. 2018 Jan;232:487-493
pubmed: 28966025
Biosci Biotechnol Biochem. 2006 Feb;70(2):525-7
pubmed: 16495673
Microb Cell Fact. 2014 Mar 03;13(1):31
pubmed: 24589366
Environ Microbiol. 2018 Mar;20(3):934-948
pubmed: 29215190
Enzyme Microb Technol. 2016 Jan;82:74-81
pubmed: 26672451
Biodegradation. 2000;11(5):331-40
pubmed: 11487063
Biochem Biophys Res Commun. 1986 Dec 15;141(2):825-30
pubmed: 3801030
Chemosphere. 2005 Sep;60(10):1471-80
pubmed: 16201028
Sci Total Environ. 2017 Jan 15;576:310-318
pubmed: 27788446
Curr Opin Biotechnol. 2016 Apr;38:1-8
pubmed: 26722717
Appl Microbiol Biotechnol. 2001 Nov;57(4):563-71
pubmed: 11762605
Mar Drugs. 2015 Jun 30;13(7):4044-136
pubmed: 26133553
J Hazard Mater. 2015 May 30;289:174-183
pubmed: 25725339
J Bacteriol. 1992 Dec;174(24):8003-7
pubmed: 1459949
Mar Pollut Bull. 2018 Apr;129(2):525-533
pubmed: 29055563

Auteurs

Efstratios Nikolaivits (E)

Industrial Biotechnology & Biocatalysis Group, Biotechnology Laboratory, School of Chemical Engineering, National Technical University of Athens, 15780 Athens, Greece. snikolai@central.ntua.gr.

Andreas Agrafiotis (A)

Industrial Biotechnology & Biocatalysis Group, Biotechnology Laboratory, School of Chemical Engineering, National Technical University of Athens, 15780 Athens, Greece. agrafiotisandreas.vep@gmail.com.

Aikaterini Termentzi (A)

Department of Pesticides Control and Phytopharmacy, Benaki Phytopathological Institute, 14561 Kifissia, Greece. a.termentzi@bpi.gr.

Kyriaki Machera (K)

Department of Pesticides Control and Phytopharmacy, Benaki Phytopathological Institute, 14561 Kifissia, Greece. k.machera@bpi.gr.

Géraldine Le Goff (G)

Institut de Chimie des Substances Naturelles, ICSN, Centre National de la Recherche Scientifique CNRS, 91198 Gif sur Yvette, France.

Pedro Álvarez (P)

iMare Natural S.L., 18600 Granada, Spain. pedro.imare@gmail.com.

Suchana Chavanich (S)

Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand. suchana.c@chula.ac.th.

Yehuda Benayahu (Y)

Department of Zoology, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel. yehudab@tauex.tau.ac.il.

Jamal Ouazzani (J)

Institut de Chimie des Substances Naturelles, ICSN, Centre National de la Recherche Scientifique CNRS, 91198 Gif sur Yvette, France. jamal.ouazzani@cnrs.fr.

Nikolas Fokialakis (N)

Division of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, University of Athens, 15771 Athens, Greece. fokialakis@pharm.uoa.gr.

Evangelos Topakas (E)

Industrial Biotechnology & Biocatalysis Group, Biotechnology Laboratory, School of Chemical Engineering, National Technical University of Athens, 15780 Athens, Greece. vtopakas@chemeng.ntua.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH